# Is Using Fondaparinux (Blood Thinner) to Treat Lung Clot Cheaper Than Traditional Therapy

> **NCT00377091** · PHASE4 · WITHDRAWN · sponsor: **University of Minnesota**

## Conditions studied

- Pulmonary Embolism

## Interventions

- **DRUG:** Fondaparinux

## Key facts

- **NCT ID:** NCT00377091
- **Lead sponsor:** University of Minnesota
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2007-06
- **Primary completion:** 2007-11
- **Final completion:** 2007-11
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Study pulled due to a grant disagreement between the U of M and SMDC
- **Last updated:** 2013-05-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00377091

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00377091, "Is Using Fondaparinux (Blood Thinner) to Treat Lung Clot Cheaper Than Traditional Therapy". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00377091. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*